Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 10, 2010 - Issue 4
Submit an article Journal homepage
66
Views
4
CrossRef citations to date
0
Altmetric
Special Report

Adjuvant therapy of pancreatic cancer

Andreas Hilbig Campus Virchow-Klinikum, Medizinische Klinik m. S. Hämatologie und Onkologie Augustenburger Platz 1, 13353 Berlin, Germany. [email protected]
&
Helmut Oettle Campus Virchow-Klinikum, Medizinische Klinik m. S. Hämatologie und Onkologie Augustenburger Platz 1, 13353 Berlin, Germany. [email protected]
Pages 485-491 | Published online: 10 Jan 2014

References

  • Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch. Surg.120, 899–903 (1985).
  • Klinkenbijl JH, Jeekel J, Sahmoud T et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative group. Ann. Surg.230, 776–782 (1999).
  • Jeekel J. Author reply to: Garofalo MC, Regine WF, Tan MT. On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer. Ann. Surg.244, 332–333 (2006).
  • Bakkevold K, Arnesjo B, Dahl O. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater – results of a controlled, prospective, randomised multicentre study. Eur. J. Cancer29A, 698–703 (1993).
  • Takada T, Amano H, Yasuda H et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A Phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer95, 1685–1695 (2002).
  • Kosuge T, Kiuchi T, Mukai K, Kakizoe T. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer. Jpn. J. Clin. Oncol.36, 159–165 (2006).
  • Neoptolemos JP, Stocken DD, Dunn JA et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann. Surg.234, 758–768 (2001).
  • Neoptolemos JP, Dunn JA, Stocken DD et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet358, 1576–1585 (2001).
  • Neoptolemos JP, Stocken DD, Friess H et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N. Engl. J. Med.350, 1200–1210 (2004).
  • Koshy MC, Landry JC, Cavanaugh SX et al. A challenge to the therapeutic nihilism of ESPAC-1. Int. J. Radiat. Oncol. Biol. Phys.61, 965–966 (2005).
  • Bydder S, Spry N. Chemotherapy for pancreatic cancer. N. Engl. J. Med.350, 2713–2715 (2004).
  • Morris SL, Beasley M, Leslie M. Chemotherapy for pancreatic cancer. N. Engl. J. Med.350, 2713–2715 (2004).
  • Regine WF, Winter KA, Abrams RA et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA299, 1019–1026 (2008).
  • Oettle H, Post S, Neuhaus P et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA297, 267–277 (2007).
  • Neuhaus P, Riess H, Post S. CONKO-001: final results of the randomized, prospective, multicentre Phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer. ASCO Annual Meeting Proceedings26(18S), (2008) (Abstract LBA4504).
  • Neoptolemos JP, Stocken DD, Tudur Smith C et al. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3 (v1) trials. Br. J. Cancer100, 246–250 (2009).
  • Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J. Am. Coll. Surg.189, 1–7 (1999).
  • Hazard L, Tward JD, Szabo A, Shrieve DC. Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data. Cancer110, 2191–2201 (2007).
  • Artinyan A, Hellan M, Mojica-Manosa P et al. Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment. Cancer112, 34–42 (2008).
  • Greene F, Page D, Fleming I et al.AJCC Cancer Staging Manual (6th Edition). Springer-Verlag, Berlin/Heidelberg, Germany (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.